Join us as we discuss BlueRock Therapeutic's new cell therapy DA01 currently in phase I clinical trials. Dr. Fasano and Dr. Enayetallah break down how this therapy has the potential to revolutionize the Parkinson's treatment landscape by providing tonic dopamine release and addressing underlying...

Join us this episode as Dr. Ziv Gan-Or breaks down lysosomal dysfunction and REM sleep behaviour disorders and how this complicates our current understanding of Parkinson's Disease. Transcript available here 

In this episode, we discuss the neuroprotective genes Parkin and PINK1, their implication in the development of early-onset Parkinson's Disease, and their possible therapeutic potential. Transcript can be found here  Questions for Dr. Trempe? Contact him at this address:...